Multivariable regression model for platelet transfusion requirements during the first 60 days after HSCT
. | Units . | P . | |
---|---|---|---|
Median . | Range . | ||
Transplant type | |||
Nonmyeloablative (n = 40) | 0 | 0 -214 | — |
Conventional (n = 67) | 24 | 4 -358 | < .001 |
Risk for transfusions | |||
Low (n = 65) | 12 | 0 -214 | — |
High (n = 42) | 28 | 0 -358 | .01 |
ABO compatibility | |||
Compatible (n = 61) | 12 | 0 -358 | — |
Major mismatch (n = 19) | 24 | 0 -214 | .14 |
Minor/minor and major mismatches (n = 27) | 18 | 0 -172 | .24 |
No. of pretransplantation platelet transfusions: continuous variable | .01 |
. | Units . | P . | |
---|---|---|---|
Median . | Range . | ||
Transplant type | |||
Nonmyeloablative (n = 40) | 0 | 0 -214 | — |
Conventional (n = 67) | 24 | 4 -358 | < .001 |
Risk for transfusions | |||
Low (n = 65) | 12 | 0 -214 | — |
High (n = 42) | 28 | 0 -358 | .01 |
ABO compatibility | |||
Compatible (n = 61) | 12 | 0 -358 | — |
Major mismatch (n = 19) | 24 | 0 -214 | .14 |
Minor/minor and major mismatches (n = 27) | 18 | 0 -172 | .24 |
No. of pretransplantation platelet transfusions: continuous variable | .01 |